Download Dr Martin Walker - Imperial College London

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Oesophagostomum wikipedia , lookup

Pandemic wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Schistosomiasis wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Syndemic wikipedia , lookup

Neglected tropical diseases wikipedia , lookup

Onchocerciasis wikipedia , lookup

Transcript
Dr Martin Walker
[email protected]
Qualifications
2006-2010
2004-2005
2001-2004
PhD Infectious Disease Epidemiology, Imperial College London
The Population Biology of Ascaris lumbricoides infections in human
MSc Control of Infectious Diseases, London School of Hygiene & Topical Medicine
BA Biological Sciences, University of Oxford
Employment
2010-present
Research Associate, Department of Infectious Disease Epidemiology,
Imperial College London
 Conduct quantitative epidemiological research on the control and elimination of
neglected tropical and parasitic diseases; to date, I have published 30 peerreviewed publications and a book chapter.
 Develop and write innovative research proposals; since 2015, I have secured
funds totalling US$241,000.
 Coordinate activities of a research group comprising Research Assistants; PhD;
MRes; MSc and University Research Opportunities Programme (UROP) students.
 Establish a network of collaborators in academic and industrial sectors including
international research consortia and non-for-profit pharmaceutical companies.
 Disseminate research findings at national and international conferences and
deliver research-based policy advice to public health agencies.
Grants and awards
2013-present
2016
2015
Honorary Lecturer, The Ear Institute, University College London
Principal Investigator Mathematical modelling of novel
macrofilaricidal drugs for river blindness: from patients to populations.
Drugs for Neglected Diseases initiative (DNDi).
Principal Investigator Evaluating variation among anthelmintic drug
response to support the control and elimination of human helminthes.
World Health Organization.
$100,593
$140,407
Teaching and supervision
Undergraduate and graduate teaching
2012-present Lecturer on the modules: Vector Borne Infections and Helminth Epidemiology and
Control and Further Infectious Disease Epidemiology; MSc Epidemiology, Imperial
College London.
2012-present Lecturer and practical organiser on Epidemiology module; BSc Biology, Imperial
College London.
2013
Invited Lecturer on Vectors of Filarial Disease; Diploma in Tropical Medicine &
Hygiene, London School of Hygiene & Tropical Medicine.
Student supervision
2013-present Co-supervisor of two PhD students at Imperial College London and
University College London.
2012-present Supervisor and co-supervisor of two five-month MRes research projects and seven
MSc dissertations.
 Two distinctions; two subsequent PhD scholarships awarded.
Short courses and capacity building
2014-present Lecturer and project co-coordinator (vector-borne diseases) for the short course for
public health professionals: Epidemiology and Control of Infectious Disease,
Imperial College London.
2012-2013
Lecturer and co-organiser of the Short Courses: Introduction to Data Analysis for
Neglected Tropical Diseases using R and Writing and Grantsmanship Skills for
Research in Neglected Tropical Diseases, Royal Society–Leverhulme Trust Capacity
Building Africa Award, Noguchi Memorial Institute for Medical Research, University
of Ghana, Legon, Ghana.
Martin Walker
2
Evidence of esteem
Invited talks
2016
Optimising macrofilaricidal drug trial design using clinical trial simulators. DNDi
Onchocerciasis Clinical and Regulatory Technical meeting. Geneva, Switzerland.
2016
Mathematical modelling to support the control and elimination of neglected tropical
diseases: from patients to populations. Royal Veterinary College, Hatfield, UK
2016
Modelling onchocerciasis elimination. 55th Mectizan Expert Committee Meeting. The
Mectizan Donation Program, Task Force for Global Health, Atlanta, Georgia, USA
2015
Modelling parasitological responses of childhood schistosome infections to treatment
with praziquantel. Schistosomiasis Data Platform Stakeholders Meeting. Geneva,
Switzerland
2015
Mathematical models for assessing the efficacy of anti-Onchocerca drugs. DNDi
Clinical Expert Meeting on Onchocerciasis. Geneva, Switzerland
2015
Alternative treatment strategies for accelerating elimination of onchocerciasis in
Africa. African Programme for Onchocerciasis Control 2nd meeting on alternative
treatment strategies. Ouagadougou, Burkina Faso
2014
Modelling new interventions for the control of onchocerciasis. Institute of Infection &
Global Health Seminar Series. University of Liverpool, Liverpool, UK
2014
Potential long-term epidemiological consequences of a vaccination programme
against onchocerciasis. 38th session of the Technical Consultative Committee of the
African Programme for Onchocerciasis Control. Ouagadougou, Burkina Faso
2012
Insights from mathematical modelling for monitoring and evaluation. 13th International
Symposium on Schistosomiasis, Belo Horizonte, Minas Gerais, Brazil
Editorial and review activities
2015-present Editorial board member of Acta Tropica
2013-present Reviewer of grant applications for the Wellcome Trust, the Coalition for Operational
Research on Neglected Tropical Diseases (COR-NTD) and the NTD Modelling
Consortium.
2011-present Reviewer of research papers for journals including: Advances in Parasitology;
Emerging Infectious Diseases; Journal of the Royal Society Interface; Lancet Global
Health; PLoS Neglected Tropical Diseases and Veterinary Parasitology.
Membership of professional bodies
2014-present
2008-present
2008-present
Fellow of the Royal Statistical Society
American Society of Tropical Medicine and Hygiene
British Society for Parasitology
Selected recent publications†
1. Crellen R*, Walker M*, Lamberton PHL, Kabatereine NB, Tukahebwa EM, Cotton JA, Webster
JP. Reduced efficacy of praziquantel against Schistosoma mansoni associated with multiplerounds of mass drug administration. Clin Infect Dis in press.
2. Frempong KF*, Walker M*, Cheke RA, Tetwvi EJ, Gyan ET, Wilson MD, Boakye DA, Taylor MJ,
Biritwum NK, Osei-Atweneboana MY, Basáñez MG. Does increasing treatment frequency
address sub-optimal responses to ivermectin for the control and elimination of river blindness?
Clin Infect Dis 2016 62:1338-1347.
3. Walker M*, Mabud T*, Olliaro PL, Coulibaly JT, King CH, Raso G, Scherrer AU, Stothard JR,
Sousa-Figueiredo JC, Stete K, Utzinger J, Basáñez MG. New approaches to measuring
anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to
treatment with praziquantel. Parasit Vectors 2016; 9:41
4. Walker M, Specht S, Churcher TS, Hoerauf A, Taylor MJ, Basáñez MG. The therapeutic
efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness.
Clin Infect Dis 2015; 60:1199-1207.
5. Walker M, Churcher TS, Basáñez MG. Models for measuring anthelmintic drug efficacy for
parasitologists. Trends Parasitol 2014; 30:528-537.
†
a complete list of publications is available in the Appendix
* contributed equally